DK1133997T3 - Beta-interferon til behandling af immunsygdomme - Google Patents

Beta-interferon til behandling af immunsygdomme

Info

Publication number
DK1133997T3
DK1133997T3 DK01103580T DK01103580T DK1133997T3 DK 1133997 T3 DK1133997 T3 DK 1133997T3 DK 01103580 T DK01103580 T DK 01103580T DK 01103580 T DK01103580 T DK 01103580T DK 1133997 T3 DK1133997 T3 DK 1133997T3
Authority
DK
Denmark
Prior art keywords
interferon
treatment
beta
immune disorders
preparation
Prior art date
Application number
DK01103580T
Other languages
Danish (da)
English (en)
Inventor
Serge Braun
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK1133997T3 publication Critical patent/DK1133997T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01103580T 2000-02-23 2001-02-20 Beta-interferon til behandling af immunsygdomme DK1133997T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00440053 2000-02-23
US24608900P 2000-11-07 2000-11-07
EP01103580A EP1133997B1 (fr) 2000-02-23 2001-02-20 L'interféron bêta pour le traitement de maladies immunes

Publications (1)

Publication Number Publication Date
DK1133997T3 true DK1133997T3 (da) 2005-04-18

Family

ID=26073631

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01103580T DK1133997T3 (da) 2000-02-23 2001-02-20 Beta-interferon til behandling af immunsygdomme

Country Status (10)

Country Link
US (1) US6906041B2 (fr)
EP (1) EP1133997B1 (fr)
JP (1) JP2001270840A (fr)
AT (1) ATE285253T1 (fr)
AU (1) AU780270B2 (fr)
CA (1) CA2334520C (fr)
DE (1) DE60107888T2 (fr)
DK (1) DK1133997T3 (fr)
ES (1) ES2234714T3 (fr)
PT (1) PT1133997E (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020197235A1 (en) * 2000-11-03 2002-12-26 Moran Stanford Mark Method for short-term and long-term drug dosimetry
DK1414379T3 (da) * 2001-08-01 2006-03-06 Anecova Sa Intrauterin anordning og fremgangsmåde til påfyldning af aktive elementer i anordningen
DE10148417A1 (de) * 2001-09-29 2003-04-17 Andreas Schwarting Verwendung von Interferon-ß zur Therapie des systemischen Lupus erythematodes
CA2498319A1 (fr) * 2002-09-09 2004-03-18 Nautilus Biotech Evolution rationnelle de cytokines pour une plus grande stabilite, les cytokines et molecules d'acide nucleique codant
EP1545432A4 (fr) * 2002-09-26 2007-03-14 Pfizer Prod Inc Utilisation d'excipients afin d'augmenter la prise d'adn par des cellules musculaires de porc
GB0405634D0 (en) 2004-03-12 2004-04-21 Univ Southampton Anti-virus therapy for respiratory diseases
CN107028760B (zh) * 2005-01-12 2019-11-01 比奥根Ma公司 运输干扰素-β的方法
WO2007030588A1 (fr) * 2005-09-07 2007-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Utilisation de replicateurs pour eviter un silencage genique
WO2007110231A2 (fr) * 2006-03-28 2007-10-04 Nautilus Biotech, S.A. POLYPEPTIDES D'INTERFÉRON-β (IFN-β) MODIFIÉS
KR20100019467A (ko) 2007-05-02 2010-02-18 암브룩스, 인코포레이티드 변형된 인터페론 베타 폴리펩티드 및 그의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration

Also Published As

Publication number Publication date
AU780270B2 (en) 2005-03-10
EP1133997A2 (fr) 2001-09-19
EP1133997B1 (fr) 2004-12-22
US6906041B2 (en) 2005-06-14
PT1133997E (pt) 2005-04-29
US20020076399A1 (en) 2002-06-20
ES2234714T3 (es) 2005-07-01
JP2001270840A (ja) 2001-10-02
EP1133997A3 (fr) 2002-06-05
DE60107888T2 (de) 2005-12-15
CA2334520C (fr) 2008-12-23
ATE285253T1 (de) 2005-01-15
DE60107888D1 (de) 2005-01-27
CA2334520A1 (fr) 2001-08-23
AU2306801A (en) 2001-08-30

Similar Documents

Publication Publication Date Title
NO20031018D0 (no) Oksymorfonpreparater med kontrollert frigivelse
NO20035474D0 (no) Prodrugs av GABA-analoger, sammensetninger og anvendelse derav
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
DK1353668T3 (da) Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer
ATE534381T1 (de) Pharmazeutische cetp-inhibitor-zusammensetzungen
ATE285753T1 (de) Lysin enthaltende kautablette
DK1262236T3 (da) Fremgangsmåde til fremstilling af formet legeme af alfa-alumina
IT1318514B1 (it) Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
PT1133997E (pt) Beta-interferao para o tratamento de doencas imunitarias
EP1352072A4 (fr) Preparations de liberation d'acide nucleique
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
NO20035352D0 (no) Legemidler for eosinofile sykdommer
BR0102847B1 (pt) peÇa Íntima descartÁvel.
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
ATE303135T1 (de) Pharmazeutische formulierungen zur gesteuerten freisetzung von 4-amino-6,7-dimethoxy-2-(5-
ITRM20030442A0 (it) Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.
ITDP20020002A1 (it) Dispositivo modulabile per l'attivazione delle arcate dentarie.
FR2819256B1 (fr) Polypeptide induisant des anticorps neutralisant le vih
MA25409A1 (fr) SERINGUE JETABLE AMéLIORéE.
IT1320253B1 (it) Composizione farmaceutica per il trattamento della malaria.
UA5323S (uk) Резервуар молоковідсмоктувача
ES1050974Y (es) Cenicero desechable.
ES1049731Y (es) Dispositivo para la administracion de farmacos.